Bruce G. Allen Investments’s GSK GSK Stock Holding History

Bruce G. Allen Investments’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$279K	Sell	5,323 -228	-4%	-$12.1K	0.18%	59
2026 Q1	$306K	Sell	5,551 -204	-4%	-$11.1K	0.2%	54
2025 Q4	$282K	Buy	5,755 +54	+0.9%	+$2.52K	0.19%	58
2025 Q3	$246K	Sell	5,701 -124	-2%	-$4.84K	0.18%	66
2025 Q2	$224K	Buy	5,825 +76	+1%	+$2.9K	0.17%	68
2025 Q1	$223K	Sell	5,749 -364	-6%	-$13.3K	0.18%	67
2024 Q4	$207K	Buy	6,113 +50	+0.8%	+$1.8K	0.17%	69
2024 Q3	$248K	Sell	6,063 -1,002	-14%	-$41K	0.19%	65
2024 Q2	$272K	Sell	7,065 -683	-9%	-$28.7K	0.23%	56
2024 Q1	$332K	Buy	7,748 +469	+6%	+$19.3K	0.27%	48
2023 Q4	$270K	Buy	+7,279	New	+$261K	0.25%	54

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bruce G. Allen Investments's GSK Position: Q2 2026 in Review

Bruce G. Allen Investments reduced its GSK (GSK) stake by 4.1% in Q2 2026, selling an estimated $12.1K and leaving 5,323 shares worth $279K. The position accounts for 0.18% of the portfolio, ranked #59.

Bruce G. Allen Investments first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. The position peaked at $332K in Q1 2024. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Bruce G. Allen Investments held 5,323 shares of GSK worth $279K as of Q2 2026.
Bruce G. Allen Investments sold 228 GSK shares in Q2 2026, an estimated $12.1K.
GSK made up 0.18% of Bruce G. Allen Investments's portfolio in Q2 2026, its #59 holding.
Bruce G. Allen Investments first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
Bruce G. Allen Investments's GSK position peaked at $332K in Q1 2024.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.